Mebeverine
Synthetic Anticholinergics, Esters With Tertiary Amino Group
Sold as COLOFAC IBS
- Drug class
- Synthetic Anticholinergics, Esters With Tertiary Amino Group
- Availability
- See label
- Markets covered
- 1
- Products on record
- 30
Overview
Mebeverine is an active pharmaceutical ingredient in the Synthetic Anticholinergics, Esters With Tertiary Amino Group group (A03AA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 30 | May 22, 2026 |
GBUnited Kingdom· MHRA
30 products
Uses
For the symptomatic treatment of irritable bowel syndrome and other conditions usually included in this grouping, such as: chronic irritable colon, spastic constipation, mucous colitis, spastic colitis. Mebeverine is effectively used to treat the symptoms of these conditions, such as: colicky abdominal pain and cramps, persistent, non-specific diarrhoea (with or without alternating constipation) and flatulence.
How to take
Sources & citations
- [1]MHRA (UK) · PL535940011 · revised March 6, 2026
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.